[Controlled trial of drugs with antispastic and antispastic-analgesic action].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001064:Appendicitis / Q000150:complications; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002764:Cholecystitis / Q000150:complications; D002769:Cholelithiasis / Q000150:complications; D003514:Cyclohexylamines / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000150:complications; D008297:Male; D008744:Methylamines / Q000627:therapeutic use*; D008875:Middle Aged; D010195:Pancreatitis / Q000150:complications; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000150:complications; D014552:Urinary Tract Infections / Q000150:complications; D014570:Urologic Diseases / Q000188:drug therapy*
D000700:Analgesics; D003514:Cyclohexylamines; D008744:Methylamines; D010276:Parasympatholytics; D011720:Pyrazoles
Sperimentazione controllata di farmaci ad azione antispastica ed antispastica-analgesica